BR0213478A - Processo de produção de heparina, e, preparação de heparina - Google Patents

Processo de produção de heparina, e, preparação de heparina

Info

Publication number
BR0213478A
BR0213478A BR0213478-0A BR0213478A BR0213478A BR 0213478 A BR0213478 A BR 0213478A BR 0213478 A BR0213478 A BR 0213478A BR 0213478 A BR0213478 A BR 0213478A
Authority
BR
Brazil
Prior art keywords
heparin
production process
preparation
production
notably
Prior art date
Application number
BR0213478-0A
Other languages
English (en)
Inventor
Pierre Cans
Jean-Marc Guillaume
Hel Ne Monique Marie Rigal
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of BR0213478A publication Critical patent/BR0213478A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

"PROCESSO DE PRODUçãO DE HEPARINA, E, PREPARAçãO DE HEPARINA". A invenção trata da produção de heparina a partir de culturas celulares de mastócitos, notadamente de mastócitos de porco.
BR0213478-0A 2001-10-22 2002-10-22 Processo de produção de heparina, e, preparação de heparina BR0213478A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0113606A FR2831186B1 (fr) 2001-10-22 2001-10-22 Production d'heparine a partir de cultures de mastocytes
PCT/FR2002/003617 WO2003035886A2 (fr) 2001-10-22 2002-10-22 Preparation d'heparine a partir de cultures de mastocytes

Publications (1)

Publication Number Publication Date
BR0213478A true BR0213478A (pt) 2004-11-03

Family

ID=8868558

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0213478-0A BR0213478A (pt) 2001-10-22 2002-10-22 Processo de produção de heparina, e, preparação de heparina

Country Status (18)

Country Link
US (1) US20050042733A1 (pt)
EP (1) EP1438415A2 (pt)
JP (1) JP2005506092A (pt)
KR (1) KR20040071127A (pt)
CN (1) CN1575341A (pt)
AR (1) AR036915A1 (pt)
BR (1) BR0213478A (pt)
CA (1) CA2462714A1 (pt)
CO (1) CO5570711A2 (pt)
FR (1) FR2831186B1 (pt)
HU (1) HUP0401794A2 (pt)
IL (1) IL161066A0 (pt)
MX (1) MXPA04003740A (pt)
NO (1) NO20041633L (pt)
NZ (1) NZ532414A (pt)
PL (1) PL368599A1 (pt)
WO (1) WO2003035886A2 (pt)
ZA (1) ZA200402304B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2853663B1 (fr) * 2003-04-14 2007-08-31 Aventis Pharma Sa Procede d'obtention de lignees de mastocytes a partir de tissus de porcs et procede de production de molecules de type heparine
FR2876386B1 (fr) * 2004-10-12 2007-04-06 Aventis Pharma Sa Lignees de mastocytes porcins produisant des molecules de type heparine
KR100688553B1 (ko) * 2005-06-22 2007-03-02 삼성전자주식회사 코어 사이즈를 감소시킨 반도체 메모리 장치
KR101447123B1 (ko) * 2014-02-27 2014-10-06 박상협 헤파린의 추출 방법
KR102104367B1 (ko) 2019-09-02 2020-04-24 팜앤바이오 주식회사 헤파린나트륨의 제조장치 및 제조방법
CN111979193A (zh) * 2019-09-27 2020-11-24 云南洛宇生物科技有限公司 大鼠骨髓源肥大细胞培养方法
CN110592165B (zh) * 2019-10-18 2021-04-27 福州大学 燕窝中硫酸乙酰肝素/肝素的提取方法与结构解析

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3016331A (en) * 1960-01-28 1962-01-09 Ormonoterapia Richter Spa Purification of heparin
AU5810690A (en) * 1989-05-19 1990-12-18 University Of Alabama, The Heparin-producing murine mastocytoma cell lines
JP3507852B2 (ja) * 1993-12-10 2004-03-15 ジェネンテク，インコーポレイテッド アレルギー診断法および抗アレルギー性治療剤のスクリーニング法
FI974321A0 (fi) * 1997-11-25 1997-11-25 Jenny Ja Antti Wihurin Rahasto Multipel heparinglykosaminoglykan och en proteoglykan innehaollande dessa
US6596705B1 (en) * 1998-02-09 2003-07-22 The Regents Of The University Of California Inhibition of L-selectin and P-selection mediated binding using heparin

Also Published As

Publication number Publication date
NZ532414A (en) 2006-12-22
KR20040071127A (ko) 2004-08-11
ZA200402304B (en) 2004-10-07
CA2462714A1 (fr) 2003-05-01
FR2831186A1 (fr) 2003-04-25
NO20041633L (no) 2004-04-21
PL368599A1 (en) 2005-04-04
MXPA04003740A (es) 2005-06-20
IL161066A0 (en) 2004-08-31
FR2831186B1 (fr) 2004-06-18
CO5570711A2 (es) 2005-10-31
WO2003035886A3 (fr) 2004-02-26
EP1438415A2 (fr) 2004-07-21
US20050042733A1 (en) 2005-02-24
HUP0401794A2 (hu) 2004-11-29
JP2005506092A (ja) 2005-03-03
AR036915A1 (es) 2004-10-13
CN1575341A (zh) 2005-02-02
WO2003035886A2 (fr) 2003-05-01

Similar Documents

Publication Publication Date Title
EP1820790A3 (en) 3-Alkylated-5,5',6,6',7,7',8,8'-octahydro-2,2'binaphthols and 3,3'-dialkylated-5,5',6,6',7,7',8,8'-octahydro-2,2'-binaphthols and process for making them
CA2390867A1 (en) Method for the production of biopolymers with modified properties
DE60040980D1 (de) Chemisch veränderte, lipolytische enzyme
BR0212654A (pt) Ativação e expansão de células
DE60140425D1 (de) Produktionsverfahren von fluorkohlenwasserstoffen
IT1302347B1 (it) Procedimento per la produzione diretta di perossido di idrogeno.
BR9810953A (pt) "processo para produzir policarbonatos ramificados"
BRPI0417659A (pt) processos de fiação giratória para a formação de fibras contendo polìmero de hidroxila
ID26310A (id) Produksi kontinyu 1,3-dioksolan-2-ona
AU2002358667A1 (en) Scented polymer capsules and the production thereof
ATE326536T1 (de) Herstellung von biologisch aktiven molekülen
IT1314300B1 (it) Linea di produzione di libri,ad elevata flessibilita' del decorsodelle funzioni di lavorazione
BR0213478A (pt) Processo de produção de heparina, e, preparação de heparina
WO2005060712A3 (en) Processes for foreshortening fibrous structures
DK1204659T3 (da) Serotonerge benzofuraner
AU144678S (en) Bottle
ITMI20011205A0 (it) Processo integrato di produzione di 2,6 dimetilfaftalene
PT1307436E (pt) Processo para a preparacao de derivados de bacatina iii
BR9807785A (pt) Processo para a preparação do composto, e, composto
FR2804696B1 (fr) Procede de fabrication d'un complexe, notamment a partir de fibres naturelles et le complexe obtenu
PT1064265E (pt) Sintese de 3-amino-2-cloro-4-metilpiridina a partir de malononitrilo e acetona
ATE251106T1 (de) Herstellung von carvon
BR0207647B1 (pt) processo de regulação de uma célula de eletrólise.
BR0316825A (pt) Processos para a preparação de um catalisador de epoxidação, e de óxido de alquileno
PT1196606E (pt) Enzima litica

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2060 DE 29/06/2010.